reformulation of sildenafil (N4 Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namereformulation of sildenafil (N4 Pharma)
Drug Alias Namesildenafilreformulation of sildenafil (N4 Pharma)N4-S001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesN4 Pharma Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN4 Pharma Plc
Active IndicationsN/A
Inactive IndicationsErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A